BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04951219-completion@plaintrial.com
DTSTAMP:20261028T041707Z
DTSTART;VALUE=DATE:202604
SUMMARY:A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MG
 L-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)\, MAEST
 RO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) — estimated completion
  date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04951219
URL:https://plaintrial.com/trial/NCT04951219
END:VEVENT
END:VCALENDAR